SBI-EMBL Scientific Meeting Interpreting Genomes & Genome Functions Science Meeting | UCD Conway Institute | 11-12 September 2017

Following the success of a 2014 event exploring opportunities for future collaborations, Systems Biology Ireland (SBI) and (European Molecular Biology Laboratory) EMBL are teaming up to host a scientific meeting on ‘Interpreting Genomes and Genome Functions’ in the Lecture Theatre of the UCD Conway Institute on the 11th and 12th September 2017. The event will comprise of a series of talks from SBI researchers, EMBL researchers and EMBL alumni and will include an EMBL Alumni Association hosted event on the evening of the 11th September. A light lunch and refreshments will also be provided.


This is a free, open invitation event; however those planning to attend should register before Friday August 25th. Registration is available via Eventbrite:


For further information regarding the event please contact Ronan Gough by email on or by telephone on 01 716 6331.

Centre Administrator

Systems Biology Ireland

University College Dublin


Dublin 4, Ireland

PH: +353-1-716-6331



Twitter: @sysbioire


European Training Network – 14 PhD positions

Applications are invited for a pan-European academic/private sector research training network in the fields of diagnostic and therapy development for brain disorders. please see the link below for further information. Submission: applicants should submit the documentation to writing on the subject line number of their selected projects (Ex: Projects 3 and 10) by Friday, November 3rd, 2017 at 5 pm (GMT).

Please see the link below for more information:

PurinesDX_job_description 26-7-17

The Cellular Bioenergetics in Neurodegenerative Diseases consortium (CeBioND) had a very successful annual meeting in the RCSI on May 22nd/23rd.

The CeBioND consortium is performing a cross disease analysis to investigate common and distinct mechanisms of mitochondrial energetic dysfunction in neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Huntington’s disease. Prof. Jochen Prehn, Dr. Niamh Connolly and Dr. Orla Watters from the Department of Physiology are the RCSI members of the international consortium, which also includes Dr. Maria Ankarcrona and Dr. Catarina Pinho from the Karolinska Institutet in Sweden, Dr. Paola Pizzo and Dr. Pierre Theurey from the University of Padova in Italy, Dr. David Park and Dr. Alvin Joselin from the University of Ottawa in Canada, and Dr. Daniele Bano and Dr. Anna Gioran from the German Center for Neurodegenerative Diseases (DZNE) in Germany.CeBionD 1CEBIOND 2More information on the CeBioND consortium can be found at


Prof. Jochen Prehn and Brain Tumor Ireland are featured in RTE news on May 25th 2017

Prof. Jochen Prehn talking about the importance of having the brain tumour biobank resource as a means to further understand the disease: see link below for more information

and news article

prehn BTI

More information can also be found

CSM was well represented at Irish Association for Cancer Research (IACR) Annual Meeting 2017 Newpark Hotel, Kilkenny

Among the speakers were:

Oral presentations:

Cíara Dunphy (Oral Poster Presentation)

Dr Catríona Dowling (Proffered Paper)

Dr Ian Miller (Irish Cancer Society Fellow Presentation)

Louise Walsh (Irish Cancer Society Scholar Presentation)


Poster Presentations:

Dr Steven Carberry

Dr Manuela Salvucci

Alessandra Di Grande

Adam Lafferty

Mariangela Meyer


Here are some pics


Mariangela Meyer PhD student presenting a poster


Alessandra Di Grande, PhD student


Dr Ian Miller (Irish Cancer Society Fellow Presentation)


Prof. Annette Byrne presents findings on the PDX model (Breast_Predict Investigator)

Prof Prehn in Sunday Times: Molecular test boost for bowel cancer treatment


Professor Jochen Prehn’s research was a focus on the Sunday Times issue 19-2-17 where he talks about how a molecular test developed at the Royal College of Surgeons in Ireland (RCSI) can predict how bowel cancer will respond to chemotherapy, ensuring that patients for whom the procedure is potentially counterproductive do not need to get the treatment.

BowelScreen, a public screening programme, can help to diagnose bowel cancers earlier than before, according to Jochen Prehn, professor of physiology and medical physics at the RCSI, who led the research team.

The test was developed when RCSI gained access to cancer tissue from 400 patients who were part of two large studies in Ireland, Europe and America of people with bowel cancer.


Jochen sunday times